Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/7/13 → 12/12/14 |
Funding
- National Cancer Institute: $3,000.00
A Phase II Pilot Study of Bortezomib(PS-341, VELCADE IND 58,443) in Combination with Intensive Re-Induction Therapy for Children with Relapsed Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)
- Giugliano, Debra (CoPI)
- Hogan, Laura (CoPI)
- Meyer, Rina (CoPI)
- Prakash, Devina (CoPI)
- Parker, Robert (PI)
- Chan, Edward (CoPI)
- Donnelly, Danielle (CoPI)
- Greenfield, Jeanne (CoPI)
- Mahan, Rosemary (CoPI)
Project: Research